[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE